Report - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · hypokalemia or hypomagnesaemia. In clinical trials, in the relapsed/refractory setting, 40% of patients In clinical trials, in the relapsed/refractory

Please pass captcha verification before submit form